Skip to main content

Radiomics Nomograms Can Predict Cochlear, Vestibular EH in Meniere Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on April 4, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, April 4, 2024 -- Novel radiomics nomograms successfully predict cochlear and vestibular endolymphatic hydrops (EH) in patients with Meniere disease, according to a study published online March 8 in European Radiology.

Wei Chen, from Fudan University in Shanghai, and colleagues enrolled 156 patients (312 affected ears) with bilateral definite Meniere disease who underwent delayed enhancement magnetic resonance imaging scans. The ears were divided into a training and internal validation set (218 and 94, respectively). A radiomics nomogram was constructed from features extracted from the T2-sampling perfection with application-optimized contrasts using different flip-angle evolutions (SPACE) images; a radiomics score was then calculated.

Construction of the cochlear radiomics nomogram included five features, and seven features were included in the vestibular radiomics nomogram. The researchers found that in both the training and validation cohorts, the radiomics nomograms exhibited robust performance for differentiating between EH-positive and EH-negative statuses, with the area under the receiver operating characteristic curve values being 0.703 and 0.728, respectively, for cochlear and vestibular radiomic nomograms in the training set and 0.718 and 0.701, respectively, in the validation set.

"The models showed a solid and superior performance and may play an important supporting role in EH prediction in situations where conventional EH imaging cannot be done properly," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Delayed Meniere Disease Tied to Higher Prevalence of Bilateral Disease

THURSDAY, Oct. 31, 2024 -- Delayed Meniere disease (DMD) is associated with a higher prevalence of bilateral Meniere disease (MD) compared with classic MD (CMD), according to a...

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.